Historical shareholding details of Wellington Global Health Care Equity holdings in Vertex Pharmaceuticals, Inc. (VRTX)

Monthly changes of Wellington Global Health Care Equity shareholding in Vertex Pharmaceuticals, Inc. over the previous months

Month Name Total no. shares held Percent Holding
Jul 31, 2025 Wellington Global Health Care Equity 116,403 0.05%
Jun 30, 2025 Wellington Global Health Care Equity 122,366 0.05%
May 31, 2025 Wellington Global Health Care Equity 124,798 0.05%
Apr 30, 2025 Wellington Global Health Care Equity 120,784 0.05%
Mar 31, 2025 Wellington Global Health Care Equity 127,939 0.05%
Feb 28, 2025 Wellington Global Health Care Equity 141,864 0.06%
Jan 31, 2025 Wellington Global Health Care Equity 158,545 0.06%
Dec 31, 2024 Wellington Global Health Care Equity 158,545 0.06%
Nov 30, 2024 Wellington Global Health Care Equity 131,852 0.05%
Oct 31, 2024 Wellington Global Health Care Equity 107,974 0.04%
Sep 30, 2024 Wellington Global Health Care Equity 99,876 0.04%
Aug 31, 2024 Wellington Global Health Care Equity 95,805 0.04%
Jul 31, 2024 Wellington Global Health Care Equity 91,960 0.04%
Jun 30, 2024 Wellington Global Health Care Equity 91,960 0.04%
May 31, 2024 Wellington Global Health Care Equity 102,120 0.04%
Apr 30, 2024 Wellington Global Health Care Equity 107,100 0.04%
Mar 31, 2024 Wellington Global Health Care Equity 109,895 0.04%
Feb 29, 2024 Wellington Global Health Care Equity 111,965 0.04%
Dec 31, 2023 Wellington Global Health Care Equity 116,625 0.05%
Nov 30, 2023 Wellington Global Health Care Equity 119,505 0.05%
Oct 31, 2023 Wellington Global Health Care Equity 129,282 0.05%
Sep 30, 2023 Wellington Global Health Care Equity 140,307 0.05%
Aug 31, 2023 Wellington Global Health Care Equity 142,622 0.06%
Jul 31, 2023 Wellington Global Health Care Equity 147,732 0.06%
Jun 30, 2023 Wellington Global Health Care Equity 152,337 0.06%
May 31, 2023 Wellington Global Health Care Equity 154,824 0.06%
Apr 30, 2023 Wellington Global Health Care Equity 157,245 0.06%

View all ownership details of Vertex Pharmaceuticals, Inc.